Among 35 cancer patients in Kentucky who said they used cannabis after diagnosis, 80% reported that their main symptom improved. Nearly 89% said their overall quality of life improved, according to a survey led by researchers at the University of Kentucky Markey Cancer Center and the Kentucky Cannabis Center.
The findings offer a snapshot of how patients are turning to cannabis while also pointing to questions that remain unanswered. Cannabis is not a proven treatment for cancer in this study, and the survey cannot show that it caused the improvements people described. But the results suggest that patients may already be using it to manage symptoms—and that doctors need the tools to discuss its possible benefits and risks clearly.
Published in The Oncologist, the study included 237 adults who had received radiation for cancer between July 2023 and February 2024. They were recruited from one urban and one rural oncology practice. Using a self-guided tablet survey, participants answered questions about symptoms, quality of life, finances and cannabis use, including how they obtained it.
Just over half of all participants said they had used cannabis without a prescription for medical reasons at some point in their lives. About 15% reported using it recently, after their cancer diagnosis. Among those 35 recent users, the most common reasons for use were pain, nausea, anxiety and depression. Eighty percent reported improvement in the main symptom they were treating, while nearly 89% reported better overall quality of life.
The answers also point to an opening for conversations in cancer clinics. Ninety-four percent of people who had recently used cannabis said they would likely discuss it with their health care providers if given the chance. Yet many rural radiation oncologists report that they have had limited formal education in cannabis pharmacology—the study of how a substance affects the body. Researchers say doctors need more training and evidence-based guidance to advise patients on issues such as dose, possible interactions with other medicines, side effects and monitoring.
“Cancer patients are already turning to cannabis for relief from symptoms related to their illness or treatment,” said Aradhana Kaushal, a radiation oncologist at Markey and the study’s principal investigator. She said patients should be able to speak openly with their care teams and get help making informed choices.
The researchers also found that a tablet survey could help include rural patients in research. The rural practice took part without a research assistant working on site, a useful approach in places where staffing and resources can be limited. Rural patients are often underrepresented in clinical studies, so simpler ways to gather their experiences could help make future research more inclusive.
Kaushal cautioned that self-reported answers cannot establish whether cannabis itself led to symptom relief. The next step, the researchers say, is to pair honest conversations with better clinical guidance and further research, so patients and doctors can weigh what is known—and what is not—together.
